Pricing
Login
Research AI
Products
Watchlists
Pricing
Login
Home
Charts
Search
Watchlist
Products
Anupam Rasayan India Ltd
ANURAS
₹
1,329.40
+0.18%
Anupam Rasayan India Ltd
ANURAS
NSE
BSE
₹
1,329.40
+0.18%
20 Nov 2026
Reports
Ask AI
Specialty Chemicals
Anupam Rasayan India Ltd
ANURAS
NSE
BSE
₹
1,329.40
+0.18%
20 Nov 2026
SOIC
x
StockScans Reports
Ask AI
Specialty Chemicals
11 indices
Business Overview: What the company does, in plain English.
Growth Catalysts: The forward growth drivers and triggers.
Guidance Report: Management guidance vs outcomes.
Deep Dive Report: In-depth business analysis.
Financials
Documents
Shareholdings
Corporate Actions
Segments
Reports
Interviews
Announcements
Financials
Documents
Shareholdings
Corporate Actions
Segments
Reports
Interviews
Announcements
Annual Reports
Quarterly Reports
FY
Annual Reports
Quarterly Reports
Submit a missing document
Interviews
8:41
Anupam Rasayan's Revenue Grows 10%, Profit Rises 14% | CNBC TV18
CNBC-TV18
·
2 weeks ago
10:57
Anupam Rasayan Completes Bliss Pharma Buy | 60-70% Utilisation Achievable In Bliss Pharma, Says Co
CNBC-TV18
·
2 months ago
3:47
अनुपम रसायन के Q1 नतीजे दमदार! EBITDA 31% बढ़ा, जानिए पूरा Outlook | Anupam Rasayan Q1 Results
CNBC Awaaz
·
3 months ago
8:54
Anupam Rasayan Raises FY27 Revenue Growth Guidance To Over 30% | CNBC TV18
CNBC-TV18
·
3 months ago
8:26
Anupam Rasayan’s Big Breakthrough! First Global ETFA Commercialization Explained | Vishal Thakkar
ET Now
·
5 months ago
6:40
Anupam Rasayan's ETFA Milestone | Flow Chemistry Helps Improve A Product's Safety Profile, Says Co
CNBC-TV18
·
5 months ago
Load More
Announcements
Announcements